特種工作各項(xiàng)健康檢查-違禁品檢測(cè)試紙

廣州健侖生物科技有限公司

我司同時(shí)有bzo - bar - coc - thc met - - opi - oxy - mdma - cfp - amp - xtc – bat多聯(lián)檢測(cè)卡（膠體金法）

我司還提供：登革熱，黃熱病，基肯孔熱，西尼羅河，立次克體，無形體，蜱蟲，恙蟲，錐蟲，利什曼原蟲，RK39, 漢坦病毒，乙腦，森林腦炎，寨卡病毒 ，H7N9 ,流感，霍亂，軍團(tuán)菌，結(jié)核，諾如病毒，輪狀病毒，炭疽，O157，葡萄球菌 ，流行性出血熱，傷寒桿菌，志賀氏菌檢測(cè)試劑,！

如需訂購或者了解請(qǐng)以下或

mob： 楊   ：  

• The One-Step Drug of Abuse Test provides only a qualitative, preliminary analytical result. A secondary analytical method must be used to obtain a confirmed result. Gas chromatography and mass spectrometry (GC/MS) is the preferred confirmatory method.
• There is a possibility that technical or procedural errors, as well as other interfering substances in the urine specimen may cause erroneous results.
• Adulterants, such as bleach and/or alum, in urine specimens may produce erroneous results regardless of the analytical method used. If adulteration is suspected, the test should be repeated with another urine specimen.
• A Positive result does not indicate level or intoxication, administration route or concentration in urine.
• A Negative result may not necessarily indicate drug-free urine. Negative results can be obtained when drug is present but below the cut-off level of the test.
• Test does not distinguish between drugs of abuse and certain medications.
• A positive test result may be obtained from certain foods or food supplements.

^{特種工作各項(xiàng)健康檢查-違禁品檢測(cè)試紙}

• Forty (40) clinical samples for each drug were run using each strip contained within the One-Step Drug of Abuse Test by an untrained operator at a Professional Point of Care site. Based on GC/MS data, the operator obtained statistically similar Positive Agreement, Negative Agreement and Overall Agreement rates as trained Laboratory personnel.

  A study was conducted at three physician offices by untrained operators using three different lots of product to demonstrate the within run, between run and between operator precision. An identical panel of coded specimens, containing drugs at the concentration of ± 50% and ± 25% cut-off level, was labeled as a blind and tested at each site
  
   

【檢測(cè)步驟】Allow the test device, urine specimen, and/or controls to reach room temperature (15-30oC) prior to te

1. Leave the bag at room temperature before opening the bag. Remove the test device in the sealed bag and use it as soon as possible.

2. Place the test device on a clean and level surface. Holding the eyedropper vertically, transfer 3 drops of complete urine (about 100 mL) to the sample well (S) of the test device and start the timer. Avoid trapped air bubbles in the sample hole (S). See below.

Wait for the color line to appear. The result should be read after 5 minutes. Do not explain the result after 10 minutes.

【檢測(cè)結(jié)果示意圖】

INTERPRETATION OF RESULTS

Negative: * Show two lines. One colored line should be in the control area (C) and the other clear colored line should be in the test area (T). This negative result shows the MOR concentration below the detectable level (1,000 ng / mL).

* Note: The color hatch in the test line area (T) will vary, but should always be considered as a negative value for any weak lines.

Front: A colored line appears in the control area (C). The test area (T) does not show any lines. This positive result indicates that the MOR concentration exceeds the detectable level (1,000 ng / mL).

Invalid: Control line can not be displayed. Inadequate sample size or incorrect procedural techniques are the most likely causes of control line failure. Review the program and repeat the test with the new test equipment. If the problem persists, stop using the lot immediay and contact your local dealer.

更多產(chǎn)品說明可通過下方的進(jìn)行了解

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【 市場部 】       楊永漢
【】 
【騰訊  】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室